Claimable, an AI-powered startup backed by Mark Cuban, is helping patients overturn health insurance denials at scale. The company addresses a widespread problem: most Americans accept rejected claims rather than fight them.
Most insurance denials go unchallenged. When insurers reject treatments prescribed by doctors, patients typically accept the decision without appealing. Claimable aims to change this dynamic by automating the appeals process.
The startup uses AI to identify denied claims with strong reversal potential, then handles the paperwork and advocacy needed to overturn them. According to the company, it has successfully reversed thousands of claims for patients.
Insurance denials often lack merit. Doctors prescribe treatments based on clinical need, but insurers frequently reject coverage citing cost considerations or formulary restrictions. Appealing these decisions is time-consuming and requires specialized knowledge of insurance policies and medical documentation—barriers that keep most patients from fighting back.
Claimable's technology streamlines this process. The platform analyzes claim denials, determines which ones are winnable, and manages the appeals process on behalf of patients. This removes friction from a system that currently favors insurers by default.
The startup's backing from Mark Cuban, the billionaire investor known for championing consumer-focused businesses, signals investor confidence in the model. Cuban has previously invested in companies addressing healthcare inefficiencies and consumer protection.
The healthcare system generates hundreds of millions of denials annually. Even if a small percentage are overturned, the financial impact for patients and the broader system is substantial. Claimable's work also creates leverage against insurers, potentially incentivizing more careful initial coverage decisions.
The company represents a broader trend of AI being applied to administrative healthcare problems. Rather than replacing doctors or making clinical decisions, Claimable uses automation to handle bureaucratic friction—an area where technology can deliver immediate, measurable value.
Whether Claimable's success will pressure insurers to reduce denials or change appeals processes remains unclear. For now, the startup is filling a gap that patients have struggled to address alone.
Metriport secured $26M in Series A and seed funding led by Matrix GP, bringing its total funding to $28.4M. The startup provides tools that enable doctors to retrieve and manage patient data.
Faro, an AI platform for clinical trial optimization, closed a $37.3 million Series B round co-led by Merck Global Health Innovation Fund and S32. The funding will support development of data models and AI tools designed to streamline trial processes.
Ajaib, a Stanford-founded stock trading app, secured $270 million in Series C funding from SBI Holdings, marking Indonesia's largest tech fundraising round since 2022.
Town, an enterprise personal AI assistant platform, is in talks to raise funding at a $1 billion valuation in a round led by Index Ventures, according to sources.